By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Astellas Pharma Inc. 

3-11 Nihonbashi-Honcho 2-chome

Chuo-ku  Tokyo  103-8411  Japan
Phone: 81-3-3244-3000 Fax: 81-3-3244-3272


SEARCH JOBS


Industry
Healthcare

Segment
Pharmaceuticals

Collaborations

Gilead (Durham, NC) 





Company News
Astellas (ALPMY) Announces Results Of Tender Offer To Acquire All Outstanding Shares Of Ocata And Changes To Subsidiaries 2/10/2016 7:57:15 AM
Astellas (ALPMY) Names James Robinson President, Americas Operations 2/8/2016 6:27:39 AM
Astellas (ALPMY) Extends Tender Offer To Acquire All Outstanding Shares Of Ocata 1/22/2016 7:33:48 AM
NanoString (NSTG) Enters Into Collaboration Agreement With Medivation (MDVN) And Astellas (ALPMY) To Develop Novel Companion Diagnostic Test 1/11/2016 1:55:41 PM
NuMedii, Inc. Announces New Indications Discovery Collaboration With Astellas (ALPMY) 1/11/2016 12:24:50 PM
NuMedii, Inc. Announces New Indications Discovery Collaboration With Astellas (ALPMY) 1/11/2016 11:48:54 AM
Astellas (ALPMY) To Present At J.P. Morgan Healthcare Conference 12/18/2015 8:18:41 AM
Bellicum (BLCM) And Astellas (ALPMY) Announce License Agreement For Cancer Target PSCA In Cell And Gene Therapy 12/11/2015 10:48:44 AM
Astellas (ALPMY) Announces Publication Of CRESEMBA (Isavuconazonium Sulfate) Pivotal Phase 3 Study Results In The Lancet 12/10/2015 6:38:49 AM
Astellas (ALPMY) Announces Updated Data From The Phase 1/2 CHRYSALIS Trial For Gilteritinib (ASP2215) In Patients With Relapsed Or Refractory Acute Myeloid Leukemia 12/7/2015 6:23:42 AM
12345678910...
//-->